Alzheimer's disease, a type of dementia that profoundly alters a person’s memory and cognitive function, affects an estimated ...

Scientists have identified a biomarker for Alzheimer's that may help doctors spot the early signs of protein buildup in the ...

Blood tests and the adoption of AI in cognitive decline screenings have opened the door to new avenues for testing cognitive ...

Researchers at the University of Queensland found that nearly 70% of suspected frontotemporal dementia patients were ...

It is based on initial research led by Dr Maura Malpetti, who received the Race Against Dementia Fellowship in 2021 from the ...

The biomarker test is a spinal tap test (also called a lumbar puncture) that uses a needle to remove cerebrospinal fluid (i.e ...

A simple blood test is being rolled out across the UK as part of a new study to detect early signs of dementia decades before ...

University of Queensland researchers discovered that nearly 70 per cent of suspected frontotemporal dementia patients ...

A new study finds that microplastics and nanoplastics accumulate at higher levels in the brain than in the liver and kidney.

Researchers discovered that nearly 70 per cent of suspected frontotemporal dementia patients ultimately did not have the disease in a study aimed at identifying factors that contribute to misdiagnosis ...

Biomarker Test Can Detect Alzheimer's Pathology Earlier Feb. 10, 2025 — Years before tau tangles show up in brain scans of patients ... suspected frontotemporal dementia patients ultimately ...